APA (7th ed.) Citation

BJ, L., D, H., N, D., CS, Z., C, S., A, G., . . . PA, G. (2025). Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research, 85(14), 2643. https://doi.org/10.1158/0008-5472.CAN-24-3686

Chicago Style (17th ed.) Citation

BJ, Laight, et al. "Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy." Cancer Research 85, no. 14 (2025): 2643. https://doi.org/10.1158/0008-5472.CAN-24-3686.

MLA (9th ed.) Citation

BJ, Laight, et al. "Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy." Cancer Research, vol. 85, no. 14, 2025, p. 2643, https://doi.org/10.1158/0008-5472.CAN-24-3686.